Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30159743 | 0.96 | ALDH1A1 (0.46) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL17416311 | 0.96 | ALDH1A1 (0.46) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL29212198 | 0.93 | TSHR (0.47) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL17424801 | 0.93 | TSHR (0.47) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL29212208 | 0.93 | TSHR (0.47) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL17424797 | 0.90 | ALDH1A1 (0.50) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL17424790 | 0.90 | ALDH1A1 (0.50) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL17424803 | 0.87 | ALDH1A1 (0.50) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL20145427 | 0.87 | ALDH1A1 (0.50) | ALDH1A1RECQLCA2CA1PKM | |
| SCHEMBL30159663 | 0.87 | ALDH1A1 (0.44) | ALDH1A1RECQLCA2CA1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12296031-B2 | Esthetic dental filling material with high depth of cure | IVOCLAR VIVADENT AG (LI) | 2025-05-13 | — | — | US | claimed |
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | IVOCLAR VIVADENT AG (LI) | 2023-08-24 | — | — | US | claimed |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | IVOCLAR VIVADENT AG (LI) | 2023-06-13 | — | — | US | claimed |
| US-20230052305-A1 | Esthetic Dental Filling Material With High Depth Of Cure | IVOCLAR VIVADENT AG (LI) | 2023-02-16 | — | — | US | claimed |
| EP-4124331-A1 | AESTHETIC DENTAL FILLING MATERIAL WITH HIGH CURING DEPTH | Ivoclar Vivadent AG (LI) | 2023-02-01 | — | — | EP | claimed |
| US-12296031-B2 | Esthetic dental filling material with high depth of cure | IVOCLAR VIVADENT AG (LI) | 2025-05-13 | — | — | US | disclosed |
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | IVOCLAR VIVADENT AG (LI) | 2023-08-24 | — | — | US | disclosed |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | IVOCLAR VIVADENT AG (LI) | 2023-06-13 | — | — | US | disclosed |
| US-20230052305-A1 | Esthetic Dental Filling Material With High Depth Of Cure | IVOCLAR VIVADENT AG (LI) | 2023-02-16 | — | — | US | disclosed |
| EP-4124331-A1 | AESTHETIC DENTAL FILLING MATERIAL WITH HIGH CURING DEPTH | Ivoclar Vivadent AG (LI) | 2023-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | MMAB, ALAD, SULT1E1 | ALDH1A1 355/4885RECQL 1236/4885CA2 3658/4885 |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | MMAB, ALAD, SULT1E1 | ALDH1A1 355/4885RECQL 1236/4885CA2 3658/4885 |
| US-12296031-B2 | Esthetic dental filling material with high depth of cure | RARA, RARG, RARB | ALDH1A1 49/4885RECQL 81/4885CA2 3940/4885 |
| US-20230052305-A1 | Esthetic Dental Filling Material With High Depth Of Cure | RARA, RARG, RARB | ALDH1A1 49/4885RECQL 81/4885CA2 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.